| No. of patients | No. of limbs | Age | Male/Female | Ethnicity | HTN | DLP | History of smoking | ESRD/on dialysis | CAD | CVD |
---|---|---|---|---|---|---|---|---|---|---|---|
Fossaceca et al., 2013 [36] | |||||||||||
 DR | 201 | - | 75.5 ± 9.5 | 136 M/65 F | - | 124 (62%) | - | - | 15 (7%) | 65 (32%) | - |
 IR | |||||||||||
  p-values | NA | - | - | - | - | - | - | - | - | - | - |
Söderström et al., 2013 [37] | |||||||||||
 DR | 226 | 121 | 68.4 ± 11.9 | 89 M/32 F | - | 89 (74%) | 78 (65%) | 24 (18%) | 26 (22%) | 69 (57%) | 29 (24%) |
 IR | 129 | 73.8 ± 11.1 | 71 M/58 F | - | 102 (79%) | 84 (65%) | 20 (24%) | 13 (10%) | 90 (70%) | 24 (19%) | |
  p-values | NA | NA | 0.001 | 0.002 | - | NS | NS | NS | 0.012 | 0.044 | NS |
 DR: propensity score matched pairs | - | 84 | 71.7 ± 11.0 | 59 M/25 F | - | 63 (75%) | 50 (60%) | 18 (25%) | 14 (17%) | 53 (63%) | 20 (24%) |
 IR: propensity score matched pairs | 84 | 70.3 ± 10.9 | 58 M/26 F | - | 63 (75%) | 60 (71%) | 15 (20%) | 12 (14%) | 55 (66%) | 17 (20%) | |
  p-values: propensity score matched pairs | NA | NA | NS | NS | - | NS | NS | NS | NS | NS | NS |
AcÃn et al., 2014 [38] | |||||||||||
 DR | 46 | - | 72 (63–78) | 30 M/16 F | - | 31 (67%) | 13 (28%) | 36 (78%) | Excluded | 17 (37%) | 9 (20%) |
 IR ‘through collaterals’ | 22 | - | 72 (68–75) | 11 M/11 F | - | 18 (82%) | 9 (41%) | 15 (68%) | Excluded | 5 (23%) | 6 (27%) |
 IR ‘without collaterals’ | 17 | - | 69 (63–77) | 9 M/8 F | - | 14 (82%) | 4 (24%) | 11 (65%) | Excluded | 4 (24%) | 3 (17%) |
  p-values: DR vs IR ‘through collaterals’ | NA | - | NS | NS | - | NS | NS | NS | NS | NS | NS |
  p-values: DR vs IR ‘without collaterals’ | NA | - | NS | NS | - | NS | NS | NS | NS | NS | NS |
Lejay et al., 2014 [39] | |||||||||||
 DR | 36 | - | 68 ± 10 | 25 M/11 F | - | 34 (95%) | 19 (53%) | 25 (69%) | 19 (53%) | 19 (53%) | 4 (11%) |
 IR | 22 | - | 71 ± 10 | 15 M/7 F | - | 21 (96%) | 12 (55%) | 16 (73%) | 12 (55%) | 12 (55%) | 2 (9%) |
  p-values | NA | - | NS | NS | - | NS | NS | NS | NS | NS | NS |
Jeon et al., 2016 [40] | |||||||||||
 DR | 70 | 63 | 69.6 ± 10 | 51 M/19 F | - | 63 (90%) | - | - | 24 (34%) | 31 (44%) | - |
 IR | 19 | ||||||||||
  p-values | NA | NA | - | - | - | - | - | - | - | - | - |